Skip to main content
. 2011 Nov 29;26(12):1556–1562. doi: 10.3346/jkms.2011.26.12.1556

Table 2.

Correlation of immunohistochemical marker and clinical outcomes of DLBCL patients

graphic file with name jkms-26-1556-i002.jpg

DLBCL, diffuse large B cell lymphoma; PFS, progression free survival; OS, overall survival.